Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Clinical and molecular allergy : CMA·2024
Same author

Safety and adverse reactions in subcutaneous allergen immunotherapy: a review.

Acta bio-medica : Atenei Parmensis·2023
Same author

Maximizing rehabilitation outcomes in geriatric hip fracture patients: the impact of surgical variables.

Acta bio-medica : Atenei Parmensis·2023
Same author

International consensus statement on allergy and rhinology: Allergic rhinitis - 2023.

International forum of allergy & rhinology·2023
Same author

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?

Acta bio-medica : Atenei Parmensis·2022
Same author

Challenges in pulmonary rehabilitation: COVID-19 and beyond.

Polish archives of internal medicine·2022

Related Experiment Video

Updated: Jun 6, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
03:23

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

Published on: May 10, 2024

[Update on eosinophilic airway disorders].

Nicola Fuiano1, Gian Galeazzo Riario-Sforza, Cristoforo Incorvaia

  • 1Servizio di Allergologia pediatrica, ASL Foggia, San Severo.

Recenti Progressi in Medicina
|December 9, 2010
PubMed
Summary

Eosinophilic airway disorders impact the nose, sinuses, bronchi, and lungs, presenting diverse conditions. Treatment primarily involves corticosteroids, with variable prognoses depending on disease severity and complications.

Area of Science:

  • Pulmonology
  • Allergy and Immunology
  • Pathology

Context:

  • Eosinophilic disorders encompass a spectrum of airway diseases affecting the upper and lower respiratory tracts.
  • These conditions include non-allergic rhinitis with eosinophilia syndrome, eosinophilic bronchitis, and various forms of eosinophilic pneumonia.
  • Distinguishing eosinophilic bronchitis from asthma is crucial due to differing functional and cytokine profiles.

Purpose:

  • To provide a comprehensive overview of eosinophilic airway disorders.
  • To differentiate related conditions such as eosinophilic bronchitis and asthma.
  • To outline the diagnostic considerations and treatment strategies for these conditions.

Summary:

  • Eosinophilic airway disorders manifest in the nose, sinuses, bronchi, and lungs, with conditions like eosinophilic bronchitis and pneumonia being key examples.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
03:23

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

Published on: May 10, 2024

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

  • Differential diagnosis is essential, particularly distinguishing eosinophilic bronchitis from asthma based on functional and cytokine data.
  • Treatment predominantly relies on corticosteroids, with prognosis varying based on complications like acute respiratory failure or systemic vasculitis.

    • Impact:

    • Improved understanding of the diverse clinical presentations of eosinophilic airway diseases.
    • Enhanced diagnostic accuracy by highlighting key differentiating features between similar conditions.
    • Guidance on corticosteroid-based treatment and prognostic factors for managing these complex respiratory disorders.